Haematological malignancies - A predictor of a poor outcome in patients with bacteraemia

Journal of Infection

Volumn 53, Issue 3, 2006, Pages 190-198

  Nørgaard, Mette ^a,b   Larsson, Heidi ^a   Pedersen, Gitte ^a   Schønheyder, Henrik Carl ^a   Sørensen, Henrik Toft ^a  

^a AALBORG UNIVERSITY HOSPITAL   (Denmark)

^b VANDERBILT INGRAM CANCER CENTER   (United States)

Author keywords

Bacteremia; Haematological malignancies; Mortality; Type of bacteraemia

Indexed keywords

ADOLESCENT; ADULT; AGED; ANAEROBIC BACTERIUM; ARTICLE; BACTEREMIA; BETA HEMOLYTIC STREPTOCOCCUS; COAGULASE NEGATIVE STAPHYLOCOCCUS; CONTROLLED STUDY; DENMARK; ESCHERICHIA COLI; FEMALE; FOLLOW UP; GRAM NEGATIVE SEPSIS; GRAM POSITIVE BACTERIUM; HEMATOLOGIC MALIGNANCY; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; POPULATION RESEARCH; PREDICTION; PROGNOSIS; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE; YEAST;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BACTEREMIA; DENMARK; FEMALE; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE BACTERIA; HEMATOLOGIC NEOPLASMS; HUMANS; MALE; MIDDLE AGED; TREATMENT OUTCOME;

EID: 33747156629     PISSN: 01634453     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jinf.2005.10.024     Document Type: Article

References (33)

1. Schønheyder H.C. Two thousands seven hundred and thirty nine episodes of bacteremia in the county of Northern Jutland 1996-1998. Presentation of a regional clinical database. Ugeskr Laeger 162 (2000) 2886-2891
2. Elhanan G., Raz R., Pitlik S.D., Sharir R., Konisberger H., Samra Z., et al. Bacteraemia in a community and a university hospital. J Antimicrob Chemother 36 (1995) 681-695
3. Lazarus H.M., Creger R.J., and Gerson S.L. Infectious emergencies in oncology patients. Semin Oncol 16 (1989) 543-560
4. Winton E.F., and Langston A.A. Update in acute leukemia 2003: a risk adapted approach to acute myeloblastic leukemia in adults. Semin Oncol 31 (2004) 80-86
5. Kipps T.J. Chronic lymphocytic leukemia. Curr Opin Hematol 7 (2000) 223-234
6. Yung L., and Linch D. Hodgkin's lymphoma. Lancet 361 (2003) 943-951
7. Raemaekers J., Kluin-Nelemans H., Teodorovic I., Meerwaldt C., Noordijk E., Thomas J., et al. The achievements of the EORTC Lymphoma Group. European Organisation for Research and Treatment of Cancer. Eur J Cancer 38 (2002) S107-S113
8. Elting L.S., Rubenstein E.B., Rolston K.V., and Bodey G.P. Outcomes of bacteremia in patients with cancer and neutropenia: observations from two decades of epidemiological and clinical trials. Clin Infect Dis 25 (1997) 247-259
9. Gonzalez-Barca E., Fernandez-Sevilla A., Carratala J., Salar A., Peris J., Granena A., et al. Prognostic factors influencing mortality in cancer patients with neutropenia and bacteremia. Eur J Clin Microbiol Infect Dis 18 (1999) 539-544
10. Gunther G., Bjorkholm M., Bjorklind A., Engervall P., and Stiernstedt G. Septicemia in patients with hematological disorders and neutropenia. A retrospective study of causative agents and their resistance profile. Scand J Infect Dis 23 (1991) 589-598
11. Johansson P.J., Sternby E., and Ursing B. Septicemia in granulocytopenic patients: a shift in bacterial etiology. Scand J Infect Dis 24 (1992) 357-360
12. Klastersky J., Zinner S.H., Calandra T., Gaya H., Glauser M.P., Meunier F., et al. Empiric antimicrobial therapy for febrile granulocytopenic cancer patients: lessons from four EORTC trials. Eur J Cancer Clin Oncol 24 Suppl.1 (1988) S35-S45
13. Hovgaard D., Skinhoj P., Bangsborg J., Bruun B., Mork H.M., and Nissen N.I. Bacteremia and candidemia in hematological malignancies: clinical findings. Scand J Infect Dis 20 (1988) 495-501
14. Pagano L., Tacconelli E., Tumbarello M., Laurenti L., Ortu-La Barbera E., Antinori A., et al. Bacteremia in patients with hematological malignancies. Analysis of risk factors, etiological agents and prognostic indicators. Haematologica 82 (1997) 415-419
15. Rintala E. Incidence and clinical significance of positive blood cultures in febrile episodes of patients with hematological malignancies. Scand J Infect Dis 26 (1994) 77-84
16. Cherif H., Kronvall G., Bjorkholm M., and Kalin M. Bacteraemia in hospitalised patients with malignant blood disorders: a retrospective study of causative agents and their resistance profiles during a 14-year period without antibacterial prophylaxis. Hematol J 4 (2003) 420-426
17. Altman D.G. Systematic reviews of evaluations of prognostic variables. BMJ 323 (2001) 224-228
18. Schønheyder H.C., and Højbjerg T. The impact of the first notification of positive blood cultures on antibiotic therapy: a one-year survey. APMIS 103 (1995) 37-44
19. Prag J., Jensen J., and Lebech K. Colorbact, a visually read blood culture system using darkening of haemoglobin in aerobic blood cultures as an early growth indicator, compared with Bactec 6A and 7A. APMIS 99 (1991) 1089-1095
20. Garner J.S., Jarvis W.R., Emori T.G., Horan T.C., and Hughes J.M. CDC definitions for nosocomial infections. Am J Infect Control 1988 16 (1988) 128-140
21. Friedman N.D., Kaye K.S., Stout J.E., McGarry S.A., Trivette S.L., Briggs J.P., et al. Health care-associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections. Ann Intern Med 137 (2002) 791-797
22. Leibovici L., Drucker M., Samra Z., Konisberger H., and Pitlik S.D. Prognostic significance of the neutrophil count in immunocompetent patients with bacteraemia. QJM 88 (1995) 181-189
23. Andersen T.F., Madsen M., Jørgensen J., Mellemkjær L., and Olsen J.H. The Danish National Hospital Register. A valuable source of data for modern health sciences. Dan Med Bull 46 (1999) 263-268
24. Charlson M.E., Pompei P., Ales K.L., and MacKenzie C.R. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40 (1987) 373-383
25. de Groot V., Beckerman H., Lankhorst G.J., and Bouter L.M. How to measure comorbidity. A critical review of available methods. J Clin Epidemiol 56 (2003) 221-229
26. Bodey G.P. Pseudomonas aeruginosa infections in cancer patients: have they gone away?. Curr Opin Infect Dis 14 (2001) 403-407
27. Arpi M., Victor M.A., Moller J.K., Jonsson V., Hansen M.M., Peterslund N.A., et al. Changing etiology of bacteremia in patients with hematological malignancies in Denmark. Scand J Infect Dis 26 (1994) 157-162
28. Leibovici L., Samra Z., Konigsberger H., Drucker M., Ashkenazi S., and Pitlik S.D. Long-term survival following bacteremia or fungemia. JAMA 274 (1995) 807-812
29. Sørensen H.T. Regional administrative health registers as a resource in clinical epidemiology. A study of options, strengths, limitations and data quality provided with examples of use. Int J Risk Safety Med 10 (1997) 1-22
30. Nørgaard M., Skriver M.V., Gregersen H., Pedersen G., Schønheyder H.C., and Sørensen H.T. The data quality of haematological malignancy ICD-10 diagnoses in a population-based Hospital Discharge Registry. Eur J Cancer Prev 14 (2005) 201-206
31. Wilchesky M., Tamblyn R.M., and Huang A. Validation of diagnostic codes within medical services claims. J Clin Epidemiol 57 (2004) 131-141
32. Kang C.I., Kim S.H., Kim H.B., Park S.W., Choe Y.J., Oh M.D., et al. Pseudomonas aeruginosa bacteremia: risk factors for mortality and influence of delayed receipt of effective antimicrobial therapy on clinical outcome. Clin Infect Dis 37 (2003) 745-751
33. Bodey G.P., Rodriguez V., Chang H.Y., and Narboni. Fever and infection in leukemic patients: a study of 494 consecutive patients. Cancer 41 (1978) 1610-1622